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Summary
Autophagy, a catabolic process responsible for the degrada-
tion of cytosolic components, is upregulated when nutrient
supplies are limited [1]. A critical step in autophagy induc-
tion comprises the inactivation of a key negative regulator
of the process, the Ser/Thr kinase mammalian target of rapa-
mycin (mTOR) [2]. Thus far, only a few substrates of mTOR
that control autophagy have been identified, including
ULK1 and Atg13 [3–5], both of which function as positive
mediators. Here we identify death-associated protein 1
(DAP1) as a novel substrate of mTOR that negatively regu-
lates autophagy. The link of DAP1 to autophagy was first
apparent in that its knockdown enhanced autophagic flux
and in that it displayed a rapid decline in its phosphorylation
in response to amino acid starvation. Mapping of the phos-
phorylation sites and analysis of phosphorylation mutants
indicated that DAP1 is functionally silenced in growing cells
through mTOR-dependent phosphorylations on Ser3 and
Ser51. Inactivation ofmTORduring starvation caused a rapid
reduction in these phosphorylation sites and converted the
protein into an active suppressor of autophagy. These
results are consistent with a ‘‘Gas and Brake’’ model in
which mTOR inhibition also controls a buffering mechanism
that counterbalances the autophagic flux and prevents its
overactivation under nutrient deprivation.
Results and Discussion
DAP1 Is a Highly Conserved Proline-Rich Phosphoprotein
Human DAP1 gene encodes a single abundant mRNA tran-
script (2.4 kb in size), which is ubiquitously expressed in
many types of cells and tissues [6]. The predicted open
reading frame of DAP1 corresponds to a small protein of 102
amino acids in length, rich in prolines (15%), and lacking any
identifiable motifs (Figure 1A). A single 17 kDa protein is trans-
lated in cells from the corresponding Flag-tagged cDNA, and
endogenous DAP1 protein runs as a single 15 kDa protein
(see Figure S1A available online). In vivo labeling of HeLa cells
with 33[P]-orthophosphate, followed by immunoprecipitation
from cells, revealed that DAP1 is a phosphoprotein in growing
cells (Figure S1B). Through database search, it was found that
DAP1 is highly conserved in evolution, and orthologs were
identified in most eukaryotes (Figures S1C and S1D).
Amino Acid Starvation Increases the Electrophoretic
Mobility of DAP1 on Gels, Indicative of Its Reduced
Phosphorylation
Several stress conditions were applied to HeLa cells to identify
a cellular setting in which DAP1 may be regulated. We found*Correspondence: adi.kimchi@weizmann.ac.ilthat, following amino acid starvation, an increase in the
steady-state levels of the protein was observed, accompanied
by an enhanced electrophoretic mobility on gels (Figure 1B).
These two regulatory events characterizing the DAP1 protein
response to amino acid deprivation were detected in all cell
lines tested, including human (HeLa, MCF7, HEK293), monkey
(COS-7), and mouse (B16, SV40 immortalized MEFs, 35-8) cell
lines (Figure 1C).
The increase in DAP1 protein levels occurred as early as
2–4 hr after culturing HeLa cells in media lacking amino
acids (EBSS), and it persisted for at least 24 hr (Figure 1B;
Figure S2A). The strong increase in protein levels was associ-
ated with only a small elevation in mRNA levels (Figure 1B), sug-
gesting thatadditional posttranscriptional regulatoryprocesses
may take place as well. DAP1 is a stable protein with a turnover
that exceeds 10 hr (Figure S2B), thus ruling out the possibility
that the rapid increase in protein steady-state levels results
from protein stabilization. Notably, the increase in DAP1 protein
takes place under conditions in which overall protein translation
is suppressed [7, 8]. As seen in Figure S2C, the short-lived
p14ARFprotein declined at the same time DAP1 protein was up-
regulated. Moreover, the increase in DAP1 protein levels during
amino acid deprivation was prevented by cycloheximide (data
not shown). Thus, in contrast to the majority of cellular proteins,
DAP1 protein translation continues and is even upregulated in
response to amino acid starvation.
The second level of DAP1 regulation, comprising the focus
of this work, involves the apparent changes in its electro-
phoretic mobility on gels. The fast-migrating form of DAP1,
which appeared concomitant with the disappearance of
the slow-migrating form characteristic of nutrient-rich condi-
tions, occurred as early as 0.5–2 hr after shifting the cultures
to EBSS and persisted for the entire starvation period
(Figure S2A). The dynamics of the changes in DAP1 electropho-
retic mobility are very rapid. Refeeding of the starved cells with
amino acids resulted in a fast upshift of the DAP1 band as early
as 0.5–1 hr post refeeding (Figure 1D; see also Figure 2E). The
identification of DAP1 as a phosphoprotein by in vivo phospho-
labeling (Figure S1B) suggests that the change in electropho-
retic mobility may represent a change in the phosphorylation
state of the protein. To test this, we immunoprecipitated
DAP1 from cells that were either starved of amino acids or
grown in nutrient-rich conditions, and we treated the captured
protein with the generic calf intestinal alkaline phosphatase
(CIP). Treatment of DAP1 immunoprecipitated from control
unstarved cells with CIP resulted in the appearance of the
fast-migrating form, whereas the slow-migrating form disap-
peared. Notably, this new band appeared at the same position
as DAP1 immunoprecipitated from starved cells, with or
without CIP treatment (Figure 1E), suggesting that the faster
form observed upon starvation is in fact dephosphorylated
DAP1. Thus, DAP1 is phosphorylated in nutrient-rich condi-
tions and undergoes dephosphorylation upon amino acid
starvation.
Mapping DAP1 Phosphorylation Sites
In order to map one or more DAP1 phosphorylation sites, we
generated stable cell lines of HEK293 cells that express
Figure 1. DAP1 Is Regulated at the Expression and Phos-
phorylation Levels during Nutrient Starvation
(A) Human DAP1 amino acid sequence. Proline residues are
marked in gray. Serines 3 and 51 are marked with asterisks.
(B) DAP1 protein levels and the corresponding mRNA
steady-state levels were measured by western blot analysis
and real-time polymerase chain reaction, respectively,
following amino acid starvation for 2 or 6 hr. Data presented
are the mean6 standard deviation (SD) calculated from trip-
licates points. *p < 0.002, Student’s t test.
(C) DAP1 protein expression following starvation in different
cell lines.
(D) DAP1 protein expression in cells that were starved for 4 hr
and then supplemented with rich medium for up to 4 hr
(refeeding). Actin was used as a loading control in (A)–(D).
(E) Immunoprecipitated DAP1 was incubated in the presence
or absence of calf intestinal alkaline phosphatase (CIP) prior
to western blot analysis with anti-DAP1 antibody. Arrowhead
points to the faster migrating band; arrow points to the
slower migrating band.
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1094DAP1 tagged with Flag at the C terminus (DAP1-Flag). Ectop-
ically expressed DAP1-Flag retained its ability to undergo the
electrophoretic mobility shift (Figure 2A). Immunopurified
DAP1-Flag was either treated or not with CIP, and after resolu-
tion on SDS-PAGE, the DAP1-Flag bands were excised and
subjected to phosphopeptide mapping analysis by liquid
chromatography-tandem mass spectrometry. Ser3 and
Ser51 of DAP1 were identified as phosphorylated residues
(Figure 1A). In addition, the N-terminal methionine was
cleaved, and Ser2 was modified by N-acetylation.
To identify the DAP1 residues that undergo dephosphoryla-
tion during starvation, we compared the ratio of phosphory-
lated and nonphosphorylated peptides in DAP1 immunopre-
cipitated from extracts of unstarved cells versus starved
cells. This comparison revealed that Ser51 is dephosphory-
lated during starvation (Figure 2B). Notably, technical difficul-
ties prevented the detection of peptides within the N-terminal
third of DAP1 in the starved sample, and therefore the status of
the phosphosite on Ser3 during starvation could not be evalu-
ated by this approach.
We next used mutagenesis as a second independent
strategy to map the phosphorylated residues that are modified
by amino acid starvation. To this end, we tested whether the
substitution of Ser3 or Ser51 to Ala or to Asp might abolish
the starvation-induced migration shift on gels. In fact, substi-
tution of Ser3 to Ala or Asp (3S/A or 3S/D, respectively) abro-
gated the gel migration shift responses to starvation
(Figure 2C, top). Furthermore, the nonphosphorylatable
mutant (3S/A) and the phosphomimetic mutant (3S/D) ap-
peared at the same positions as the dephosphorylated and
phosphorylated forms of the wild-type (WT) construct, respec-
tively. These results indicate that Ser3 is also dephosphory-
lated upon starvation and that the loss of the phosphate
residue on this site is responsible for the migration shift on
gels. (Because these experiments were performed in tran-
siently transfected cells, variations in steady-state levels of
the ectopically expressed proteins are not relevant and vary
among experiments).
Notably, the substitution of Ser51 to Ala or Asp (51S/A or
51S/D, respectively) did not abolish the gel migration shift
upon starvation (Figure 2C, middle). Thus, the starvation-
induced dephosphorylation of Ser51 detected by the massspectrometry analysis does not confer any conformational or
electrostatic changes that can be detected by altered electro-
phoretic mobility. The double mutants 3,51SS/AA and
3,51SS/DD, as expected, ran on gels in the same pattern as
the single mutations of Ser3 (Figure 2C, bottom).
To further follow the fate of Ser51 phosphorylation in cells,
we generated anti-phospho-Ser51 antibodies. These anti-
bodies recognize the ectopically expressed WT protein but
fail to detect the 51S/A mutant (Figure 2D). At the endogenous
level, amino acid starvation resulted in a significant decrease
in the phospho-Ser51 signal, whereas total DAP1 protein
was markedly elevated at this time point (Figure 2E), indicating
by a second independent approach that endogenous
DAP1 protein undergoes dephosphorylation on Ser51 during
starvation.Identifying mTOR as the Specific Kinase of DAP1
Reculturing the starved cells in complete medium (refeeding)
restored the phosphorylation on both sites, as detected by
the return of the slowly migrating band and by the increase
in phospho-Ser51 signal (Figure 2E), demonstrating that the
changes in Ser3 and Ser51 phosphorylation are very dynamic.
These rapid changes in DAP1 phosphorylation state during
starvation and refeeding experiments prompted us to search
for the specific kinase of DAP1. Notably, DAP1 phosphoryla-
tion state on Ser3 and Ser51 correlated with the activity of
mTOR in cells, showing a dynamic profile that is similar to
other mTOR substrates, such as p70S6K (Figure 2E) and 4E-
BP1 (data not shown). Interestingly, Ser3 and Ser51 phosphor-
ylation sites fall within ‘‘proline-directed’’ motifs like those
identified in 4E-BP1 [9], which are known to be phosphorylated
by mTOR [10, 11]. As a first approach to determine whether
DAP1 is phosphorylated by mTOR in vivo, HeLa cells were
treated with Torin1, a specific ATP-competitive inhibitor of
mTOR [12], and the status of phospho-Ser3 and Ser51 was
monitored by the mobility shift of DAP1 in gel and by the
decline of the phospho-Ser51 signal, respectively. It was found
that the phosphorylation of both Ser3 and Ser51 was strongly
attenuated in response to Torin1 treatment (Figure 2F),
demonstrating that phosphorylation of DAP1 was significantly
attenuated in response to mTOR inhibition in vivo.
Figure 2. DAP1 Is a Direct Substrate of mTOR
(A) HEK293 polyclonal cells stably expressing DAP1-Flag were cultured in rich medium or were starved for 4 hr, and cell lysates were subjected to western
blotting with anti-Flag antibodies. Tubulin was used as a loading control.
(B) The HEK293 polyclonal stable transfectants were either starved or cultured in rich medium for 4 hr, and DAP1-Flag was immunoprecipitated and resolved
by SDS-PAGE. The gel was stained with GelCode, and the DAP1-Flag bands in each fraction were excised and analyzed by liquid chromatography-tandem
mass spectrometry, as shown in the graphs. Each peak represents a peptide; open red circles mark the unphosphorylated peptides containing Ser51
(marked in red), and open blue circles mark the phosphopeptides containing phosphorylated Ser51 (marked in blue with an asterisk). The graph height
represents the relevant abundance of the peptide in the fraction. Left graph, unstarved cells; right graph, starved cells.
(C) HEK293T cells transfected with wild-type (WT) or mutant DAP1 at the indicated residue or residues were cultured in rich medium or starved for 6 hr.
Lysates were subjected to western blotting with anti-Flag antibodies. Arrowhead points to the faster migrating band; arrow points to the slower migrating
band.
(D) HeLa cells transfected with WT or Ser51Ala mutant DAP1-Flag were cultured in rich medium or starved for 6 hr. Lysates were subjected to western blot-
ting with anti-Flag and anti-phospho-Ser51 DAP1 (pSer51) antibodies.
(E) Lysates from HeLa cells that were starved for 3 hr and then recultured in complete medium (refeeding) for up to 4 hr were subjected to western blotting
with anti-DAP1, anti-phospho-Ser51 DAP1 (pSer51), and anti-phospho-Thr389 p70S6K (p-p70S6K) antibodies.
(F) HeLa cells were treated with Torin1 or dimethyl sulfoxide (control) or were cultured in rich medium (unstarv.) or in EBSS (starved) for 3 hr. Lysates were
subjected to western blotting as in (E).
(G) Immunopurified mTOR (bottom) was incubated with recombinant His-DAP1 or GST-4E-BP1 in the presence or absence of ATP or Torin1. Equal quan-
tities of substrates assayed were verified by Ponceau staining.
(H) HeLa cells were treated with EBSS (starved) or with 100 nM of rapamycin (rapa.) for 2 hr, and cell lysates were subjected to western blotting as in (E).
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similarly affected by Torin1.
Next, endogenous mTOR was immunoprecipitated from
HEK293T cells and subjected to in vitro kinase assays with
bacterially produced recombinant His-DAP1 or GST-4E-BP1
as substrates. Figure 2G shows that mTOR phosphorylates
His-DAP1 on Ser51, as detected by the anti-phospho-Ser51
antibody. GST-4E-BP1 phosphorylation was monitored by
using anti-phospho-Thr37/46 antibody. Additionally, the phos-
phorylation of both substrates was attenuated in vitro in the
presence of Torin1, proving that purified cellular mTOR
directly phosphorylates DAP1. Notably, mTOR exists in cells
in two multiprotein complexes, mTOR complex 1 (mTORC1)
and mTORC2, the former displaying strong sensitivity to the
drug rapamycin [2]. Figure 2H shows that treatment withrapamycin resulted in dephosphorylation of both Ser3 and
Ser51 of DAP1, demonstrating that mTORC1 phosphorylates
DAP1 in cells.
DAP1 Knockdown Increases Autophagy
To study the functional outcome of DAP1 knockdown on au-
tophagy induced by nutrient deprivation, we generated
polyclonal and monoclonal HeLa cells stably expressing
GFP-LC3. LC3, one of the autophagy (Atg) genes involved in
autophagosome formation, associates with the autophago-
some membrane in its lipidated form, thus serving as a marker
for autophagosomes [13, 14].
DAP1 was knocked down in the GFP-LC3 polyclonal stable
clones before exposing the cells to EBSS. As shown in Figures
3A and 3B, during starvation there is a strong increase in the
Figure 3. DAP1 Knockdown Increases Autophagic Flux
(A) A polyclonal population of HeLa cells stably expressing GFP-LC3 was transfected with DAP1-targeting small hairpin RNA (shRNA) or HcRed shRNA as
control for 5 days and then starved for 2 or 6 hr. Cells were fixed with 3.7% formaldehyde and were analyzed by fluorescent microscopy. Scale bar represents
20 mm.
(B) Quantitation of the percentage of cells with punctate GFP-LC3 fluorescence per total GFP-LC3-positive cells. Data represent mean6 SD calculated from
triplicates of 100 transfected cells each. *p < 0.02.
(C) Western blot analysis with indicated antibodies of extracts from GFP-LC3 stably expressing cells transfected with DAP1 or HcRed shRNA. The quantified
values of free GFP levels for each sample are indicated at the bottom.
(D) HeLa cells stably expressing GFP-LC3 (clone 7) were transfected with DAP1 or HcRed small interfering RNA (siRNA) for 3 days and then either cultured in
rich medium or starved in the presence or absence of lysosomal inhibitors (E64d [10 mg/ml] + pepstatin A [10 mg/ml]) for 4 hr. Cells were fixed as in (A) and
analyzed as in (B).
(E) Western blot analysis of cell extracts prepared from siRNA-transfected cells (clone 7) reacted with the indicated antibodies. The ratio of LC3-II/LC3-I
measured for each sample is indicated at the bottom.
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total GFP-LC3-positive cells in DAP1 knockdown cells in
comparison tocontrol small hairpin RNA (shRNA)cells.Western
blot analysis demonstrated that as early as 2 hr after starvation,
free GFP accumulated to a greater extent in cells lacking DAP1
(Figure 3C). During starvation, autophagosomal intraluminal
GFP-LC3 is degraded in the autolysosomes, and free GFP
accumulates because it is relatively stable to lysosomal prote-
ases. Thus, increased accumulation of free GFP in DAP1 knock-
down cells reinforces the point that knockdown of DAP1
increases autophagic activity rather than blocking later stages
of autolysosome maturation or degradation. Similar accelera-
tion of autophagosome formation was obtained when the
knockdown experiments were performed in a GFP-LC3 mono-
clonal stable cell line (clone 7) and with another DAP1 shRNA
vector to exclude off-target effects (Figures S3A–S3C). Autoph-
agy was also quantified by automated software measuring the
total area of GFP-LC3 puncta per cell. Figure S3D demonstrates
that, during starvation, the total area of GFP-LC3 puncta per cell
is significantly increased by the knockdown of DAP1 in compar-
ison to control small interfering RNA (siRNA) cells.
These results were also confirmed by western blotting for
endogenous LC3, which, when conjugated to phosphatidyl-
ethanolamine (LC3-II), migrates as a faster form on gels
(at 16 kDa versus 18 kDa for the unconjugated LC3-I). DAP1
knockdown by either one of the two shRNAs caused a signifi-
cant increase in the LC3-II/LC3-I ratio, as detected at 2 and 4 hr
of amino acid deprivation (Figure S3E), indicating that DAP1
knockdown accelerated autophagosome formation. Inhibitors
of lysosomal activity (E64d and pepstatin A) did not abrogate
the stimulatory effect of DAP1 knockdown on autophagy, but
rather contributed to a significant, further elevation in the
GFP-LC3 punctate staining (p < 0.03, t test, DAP1 siRNA +
inhibitors versus DAP1 siRNA 2 inhibitors) (Figure 3D). Inaddition, the ratio between LC3-II and LC3-I on blots was
elevated in DAP1-depleted cells during starvation and
increased even more when the lysosomal inhibitors were
added (Figure 3E). These results prove that the increased
accumulation of autophagosomes in cells lacking DAP1
results from enhancement of autophagic activity rather than
from blockage of late stages of the process.
In conclusion, the knockdown experiments performed using
three different DAP1 RNA interference constructs (two shRNAs
and one siRNA pool), several clones of GFP-LC3 stably
expressing cells, and a few methods to monitor autophagy
suggest that DAP1 plays a suppressive role in the autophagy
process.
Dephosphorylation of DAP1 Activates the Suppressive
Function of the Protein in Autophagy
In order to test whether the dephosphorylation of DAP1 acti-
vates or inactivates the autophagic suppressive effects, the
WT DAP1, phosphomimetic (3,51SS/DD), or nonphosphorylat-
able (3,51SS/AA) mutants were introduced into GFP-LC3
transfectants in which the endogenous protein was knocked
down by using an individual siRNA that targets the 30 untrans-
lated region (UTR) of DAP1 mRNA. These siRNAs, although
effective against the endogenous DAP1, did not affect the
ectopically expressed mutants that were generated from
a DAP1 construct that lacks the 30UTR (Figure 4B). During star-
vation, the 3,51SS/AA mutant blocked the increase in autopha-
gosome accumulation observed upon knockdown of DAP1,
whereas the 3,51SS/DD mutant failed to restore the response
to the level of the control siRNA transfected cells (Figure 4A).
Notably, the overexpressed WT protein was also active in
these experiments, because it underwent strong dephosphor-
ylation. These results demonstrate that the dephosphorylated
form of DAP1 is the active form that suppresses autophagy.
Figure 4. Dephosphorylation of DAP1 Activates Its Suppres-
sive Function in Autophagy
(A) Clone 7 GFP-LC3 HeLa cells were cotransfected with
siRNA to endogenous DAP1 or HcRed, together with lucif-
erase (Luc), WT, or mutated DAP1-Flag plasmids, for
3 days and were then either cultured in rich medium
(unstarved) or starved of amino acids for 4 hr. Cells were
fixed and analyzed by fluorescence microscopy. Graph
indicates the percentage of cells with punctate GFP-LC3
fluorescence per total GFP-LC3-positive cells as a mean 6
SD calculated from triplicates of 100 transfected cells
each. *p < 0.03. (Note that statistical comparison of the
various control siRNA-expressing cells under starvation,
including those expressing the nonphosphorylatable mutant
[3,51SS/AA] [gray bars, right, starved], indicated no signifi-
cant difference in autophagosome accumulation).
(B) Western blot analysis of lysates from (A) reacted with
anti-DAP1 or anti-Tubulin (as loading control) antibodies.
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DEPTOR or PRAS40, which are regulated by mTOR, also in
turn control mTOR activity [15–17], it was of interest to test
whether a bidirectional interaction might also exist in the
case of DAP1. In this model, the functional dephosphorylated
form of DAP1 would negatively regulate autophagy by
enhancing mTOR activity, and therefore its knockdown should
further suppress mTOR activity during autophagy. To this end,
we knocked down DAP1 in GFP-LC3 stably expressing cells
that were either starved or treated with rapamycin, and we
used the phosphorylation status of 4E-BP1 and p70S6K to
evaluate mTOR activity in cells. Figure S4A shows the
expected increase in autophagic activity in DAP1 knockdown
cells during both starvation and rapamycin. However, mTOR
activity was not affected by DAP1 knockdown, and the reduc-
tion in 4E-BP1 phosphorylation, as monitored by the nonphos-
pho-Thr46 antibody and by the migration shifts identified by
total 4E-BP1 antibody, was not further enhanced by knocking
down DAP1 (note that p70S6K is completely dephosphory-
lated upon induction of autophagy and therefore was not
a useful marker in these experiments) (Figure S4B). Based on
these results, we conclude that DAP1, a substrate of mTOR,
does not feed back on mTOR activity upon its dephosphoryla-
tion.
Altogether, this work highlights the important role that DAP1
has in autophagy regulation. Some preliminary in vivo docu-
mentation of the involvement of DAP1 in autophagy was
recently provided in a planarian remodeling system in which
expression of the planarian DAP1 ortholog is activated in the
population of cells undergoing autophagy during the remodel-
ing/regeneration process [18]. To date, little is known about
suppressors of autophagy, and only a few have been identi-
fied, including mTOR and several members of the Bcl-2 family
[2, 19, 20]. In this work, we have identified DAP1 as
a suppressor of autophagy and as a novel substrate of
mTOR. We propose that its suppressive function, acquired
once the inhibitory phosphorylations are removed by mTOR
inactivation, may restrict the intensity of the autophagic flux
to maintain the continuous benefits of this process under
stress. Notably, another way to balance the extent of autoph-
agy is by turning off p70S6K, a positive mediator of autophagy,
through mTOR inhibition [21]. The conversion of DAP1 into anactive suppressor of autophagy by dephosphorylation fits
a ‘‘Gas and Brake’’ model in which mTOR, the main regulator
of autophagic induction, also simultaneously controls the
activity of a specific balancing brake aimed at limiting the
extent of the autophagic response to maintain the proper
homeostatic balance.
Supplemental Information
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at doi:10.1016/j.
cub.2010.04.041.
Acknowledgments
We thank S. Bialik for her continuous advice and for reading and discussing
the manuscript. We thank S. Ben-Dor from the Bioinformatics and Biological
Computing Unit at the Weizmann Institute of Science for performing the bi-
oinformatics analysis. We thank G. Jona, Director of the Protein Purification
Center at the Weizmann Institute of Science, for expression and purification
of recombinant proteins. We thank The Smoler Proteomic Center (Technion,
Haifa, Israel) for performing the mass spectrometry analysis. This work was
supported by the Kahn Fund for Systems Biology at the Weizmann Institute
of Science, by a Center of Excellence grant from the Flight Attendant
Medical Research Institute, and by a grant from the European Union FP7
to APO-SYS. A.K. is the incumbent of the Helena Rubinstein Chair of Cancer
Research.
Received: January 28, 2010
Revised: April 18, 2010
Accepted: April 19, 2010
Published online: May 27, 2010
References
1. Yang, Z., and Klionsky, D.J. (2010). Mammalian autophagy: Core molec-
ular machinery and signaling regulation. Curr. Opin. Cell Biol. 22,
124–131.
2. Laplante, M., and Sabatini, D.M. (2009). mTOR signaling at a glance.
J. Cell Sci. 122, 3589–3594.
3. Jung, C.H., Jun, C.B., Ro, S.H., Kim, Y.M., Otto, N.M., Cao, J., Kundu,
M., and Kim, D.H. (2009). ULK-Atg13-FIP200 complexes mediate
mTOR signaling to the autophagy machinery. Mol. Biol. Cell 20,
1992–2003.
4. Ganley, I.G., Lam, H., Wang, J., Ding, X., Chen, S., and Jiang, X. (2009).
ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essen-
tial for autophagy. J. Biol. Chem. 284, 12297–12305.
Current Biology Vol 20 No 12
10985. Hosokawa, N., Hara, T., Kaizuka, T., Kishi, C., Takamura, A., Miura, Y.,
Iemura, S., Natsume, T., Takehana, K., Yamada, N., et al. (2009).
Nutrient-dependent mTORC1 association with the ULK1-Atg13-
FIP200 complex required for autophagy. Mol. Biol. Cell 20, 1981–1991.
6. Deiss, L.P., Feinstein, E., Berissi, H., Cohen, O., and Kimchi, A. (1995).
Identification of a novel serine/threonine kinase and a novel 15-kD
protein as potential mediators of the gamma interferon-induced cell
death. Genes Dev. 9, 15–30.
7. Dann, S.G., and Thomas, G. (2006). The amino acid sensitive TOR
pathway from yeast to mammals. FEBS Lett. 580, 2821–2829.
8. de Haro, C., Me´ndez, R., and Santoyo, J. (1996). The eIF-2alpha kinases
and the control of protein synthesis. FASEB J. 10, 1378–1387.
9. Gingras, A.C., Raught, B., Gygi, S.P., Niedzwiecka, A., Miron, M., Burley,
S.K., Polakiewicz, R.D., Wyslouch-Cieszynska, A., Aebersold, R., and
Sonenberg, N. (2001). Hierarchical phosphorylation of the translation
inhibitor 4E-BP1. Genes Dev. 15, 2852–2864.
10. Burnett, P.E., Barrow, R.K., Cohen, N.A., Snyder, S.H., and Sabatini,
D.M. (1998). RAFT1 phosphorylation of the translational regulators
p70 S6 kinase and 4E-BP1. Proc. Natl. Acad. Sci. USA 95, 1432–1437.
11. Gingras, A.C., Gygi, S.P., Raught, B., Polakiewicz, R.D., Abraham, R.T.,
Hoekstra, M.F., Aebersold, R., and Sonenberg, N. (1999). Regulation of
4E-BP1 phosphorylation: A novel two-step mechanism. Genes Dev. 13,
1422–1437.
12. Thoreen, C.C., Kang, S.A., Chang, J.W., Liu, Q., Zhang, J., Gao, Y.,
Reichling, L.J., Sim, T., Sabatini, D.M., and Gray, N.S. (2009). An ATP-
competitive mammalian target of rapamycin inhibitor reveals rapamy-
cin-resistant functions of mTORC1. J. Biol. Chem. 284, 8023–8032.
13. Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda,
T., Kominami, E., Ohsumi, Y., and Yoshimori, T. (2000). LC3, a mamma-
lian homologue of yeast Apg8p, is localized in autophagosome
membranes after processing. EMBO J. 19, 5720–5728.
14. Mizushima, N., Yamamoto, A., Hatano, M., Kobayashi, Y., Kabeya, Y.,
Suzuki, K., Tokuhisa, T., Ohsumi, Y., and Yoshimori, T. (2001). Dissec-
tion of autophagosome formation using Apg5-deficient mouse embry-
onic stem cells. J. Cell Biol. 152, 657–668.
15. Peterson, T.R., Laplante, M., Thoreen, C.C., Sancak, Y., Kang, S.A.,
Kuehl, W.M., Gray, N.S., and Sabatini, D.M. (2009). DEPTOR is an
mTOR inhibitor frequently overexpressed in multiple myeloma cells
and required for their survival. Cell 137, 873–886.
16. Oshiro, N., Takahashi, R., Yoshino, K., Tanimura, K., Nakashima, A.,
Eguchi, S., Miyamoto, T., Hara, K., Takehana, K., Avruch, J., et al.
(2007). The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiolog-
ical substrate of mammalian target of rapamycin complex 1. J. Biol.
Chem. 282, 20329–20339.
17. Sancak, Y., Thoreen, C.C., Peterson, T.R., Lindquist, R.A., Kang, S.A.,
Spooner, E., Carr, S.A., and Sabatini, D.M. (2007). PRAS40 is an
insulin-regulated inhibitor of the mTORC1 protein kinase. Mol. Cell 25,
903–915.
18. Gonza´lez-Este´vez, C., Felix, D.A., Aboobaker, A.A., and Salo´, E. (2007).
Gtdap-1 promotes autophagy and is required for planarian remodeling
during regeneration and starvation. Proc. Natl. Acad. Sci. USA 104,
13373–13378.
19. Maiuri, M.C., Le Toumelin, G., Criollo, A., Rain, J.C., Gautier, F., Juin, P.,
Tasdemir, E., Pierron, G., Troulinaki, K., Tavernarakis, N., et al. (2007).
Functional and physical interaction between Bcl-X(L) and a BH3-like
domain in Beclin-1. EMBO J. 26, 2527–2539.
20. Pattingre, S., Tassa, A., Qu, X., Garuti, R., Liang, X.H., Mizushima, N.,
Packer, M., Schneider, M.D., and Levine, B. (2005). Bcl-2 antiapoptotic
proteins inhibit Beclin 1-dependent autophagy. Cell 122, 927–939.
21. Scott, R.C., Schuldiner, O., and Neufeld, T.P. (2004). Role and regulation
of starvation-induced autophagy in the Drosophila fat body. Dev. Cell 7,
167–178.
